TCRX - TScan Therapeutics GAAP EPS of -$0.32 revenue of $0.56M May, 13 2024 09:19 AM TScan Therapeutics Inc. 2024-05-13 09:19:26 ET More on TScan Therapeutics TScan Therapeutics prices upsized stock offering to raise $150 million Seeking Alpha’s Quant Rating on TScan Therapeutics Historical earnings data for TScan Therapeutics Financial information for TScan Therapeutics For further details see: TScan Therapeutics GAAP EPS of -$0.32, revenue of $0.56M